The Brigham and Women's Hospital, Inc.

The Charles Stark Draper Laboratory, Inc.

Sophia Koo

Francisco Miguel Marty

Lindsey Robert Baden

Horatio R Thomas

James Constantine Comolli

Preshious Rearden

Methods for diagnosing, treating, and monitoring the treatment of fusariosis or scedosporiosis are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having fusariosis or scedosporiosis.

Diagnosis and treatment of Fusariosis and Scedosporiosis

Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.

Diagnosis and treatment of invasive aspergillosis

Methods for diagnosing, treating, and monitoring the treatment of mucormycosis are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having mucormycosis.

Volatile metabolite profiles for the diagnosis and treatment of Mucorales fungi

Methods for diagnosing, treating, and monitoring the treatment ofinfections (CDI), e.g.,-Associated Diarrhea (CDAD). The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in a sample from ambient air or stool sample from subjects suspected of having a CDI, e.g., CDAD.

Growing community of inventors

Brookline, MA, United States of America

Sophia Koo